September 17, 2015
FDA approves Vraylar for treatment of bipolar I disorder and schizophrenia
Allergan plc and Gedeon Richter Plc. have announced that the U.S. Food and Drug Administration (FDA) has approved Vraylartm (cariprazine) capsules,…